A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Name: A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Published: 2019
License: Public Domain

Syndax Pharmaceuticals · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

acute-myeloid-leukemia

acute myeloid leukemia, acute lymphoblastic leukemia, mixed lineage acute leukemia, mixed phenotype acute leukemia, acute leukemia of ambiguous lineage, aml, all, mpal, mlal, alal, relapsed leukemia, refractory leukemia

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 903424
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.